X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (80) 80
particle physics (77) 77
physics (76) 76
high energy physics - experiment (75) 75
physics - high energy physics - experiment (70) 70
fysik (64) 64
natural sciences (64) 64
naturvetenskap (64) 64
physical sciences (64) 64
physics of elementary particles and fields (63) 63
physics, particles & fields (55) 55
high energy physics (44) 44
物理学 (40) 40
elementary particles, quantum field theory (28) 28
quantum field theories, string theory (28) 28
hep (27) 27
large hadron collider (27) 27
collisions (25) 25
phenomenology (25) 25
ex (22) 22
astronomy, astrophysics and cosmology (21) 21
detectors (20) 20
measurement science and instrumentation (19) 19
nuclear energy (19) 19
nuclear physics, heavy ions, hadrons (19) 19
cern lhc coll (18) 18
hadron-hadron scattering (18) 18
nuclear experiment (17) 17
parton distributions (17) 17
regular - experimental physics (16) 16
astronomy & astrophysics (15) 15
experimental results (15) 15
subatomic physics (14) 14
subatomär fysik (14) 14
particle collisions (13) 13
standard model (13) 13
decay (12) 12
hadron (12) 12
luminosity (12) 12
p p: scattering (11) 11
quarks (11) 11
transverse momentum (11) 11
instruments & instrumentation (10) 10
p p: colliding beams (10) 10
searching (10) 10
astrophysics (9) 9
classical and quantum gravitation, relativity theory (9) 9
instrumentation and detectors (9) 9
leptons (9) 9
quantum physics (9) 9
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (8) 8
collision dynamics (8) 8
computer simulation (8) 8
higgs bosons (8) 8
jets (8) 8
lhc (8) 8
pair production (8) 8
physics, nuclear (8) 8
program (8) 8
protons (8) 8
supersymmetry (8) 8
elektron (7) 7
hadrons (7) 7
high energy astrophysical phenomena (7) 7
rekonstruktion (7) 7
scattering [p p] (7) 7
13000 gev-cms (6) 6
atlas (6) 6
confidence intervals (6) 6
physics, multidisciplinary (6) 6
7000 gev-cms8000 gev-cms (5) 5
analysis (5) 5
bosons (5) 5
colliding beams [p p] (5) 5
comparative analysis (5) 5
data analysis method (5) 5
hadron colliders (5) 5
lepton (5) 5
mass dependence (5) 5
measurement (5) 5
particle accelerators (5) 5
particle tracking detectors (5) 5
performance of high energy physics detectors (5) 5
plus plus (5) 5
pp collisions (5) 5
proton (5) 5
accident reconstruction (4) 4
algorithms (4) 4
background (4) 4
cross-section (4) 4
dark matter (4) 4
distributions (4) 4
efficiency (4) 4
eichen (4) 4
extension (4) 4
generator (4) 4
higgs physics (4) 4
kalorimeter (4) 4
mass (4) 4
model (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9992, pp. 444 - 451
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1389 - 1398
Summary Background In the COMBI-v trial, patients with previously untreated BRAF Val600Glu or Val600Lys mutant unresectable or metastatic melanoma who were... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | EQ-5D | QUESTIONNAIRE QLQ-C30 | ONCOLOGY | SCORES | RELIABILITY | EUROPEAN-ORGANIZATION | CANCER | VALIDITY | Prospective Studies | Skin Neoplasms - drug therapy | Oximes - adverse effects | Humans | Oximes - administration & dosage | Protein Kinase Inhibitors - adverse effects | Indoles - administration & dosage | Time Factors | DNA Mutational Analysis | Imidazoles - therapeutic use | MAP Kinase Kinase Kinases - antagonists & inhibitors | Genetic Predisposition to Disease | Administration, Oral | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Risk Factors | MAP Kinase Kinase Kinases - metabolism | Disease Progression | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Protein Kinase Inhibitors - administration & dosage | Phenotype | Indoles - adverse effects | Intention to Treat Analysis | Quality of Life | Indoles - therapeutic use | Biomarkers, Tumor - genetics | Pyrimidinones - administration & dosage | Mutation | Sulfonamides - administration & dosage | Melanoma - mortality | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Oximes - therapeutic use | Pyridones - administration & dosage | Melanoma - genetics | Skin Neoplasms - mortality | Surveys and Questionnaires | Skin Neoplasms - pathology | Drug Administration Schedule | Treatment Outcome | Melanoma - secondary | Disease-Free Survival | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Sulfonamides - adverse effects | Pyridones - therapeutic use | Pyridones - adverse effects | Care and treatment | Hospitals | Metastasis | Gene mutations | Comparative analysis
Journal Article
European Physical Journal C, ISSN 1434-6044, 2017, Volume 77, Issue 7, pp. 1 - 73
Journal Article
Journal Article
by Aad, G and Abbott, B and Abdallah, J and Abdel Khalek, S and Abdinov, O and Aben, R and Abi, B and Abolins, M and AbouZeid, O S and Abramowicz, H and Abreu, H and Abreu, R and Abulaiti, Y and Acharya, B S and Adamczyk, L and Adams, D L and Adelman, J and Adomeit, S and Adye, T and Agatonovic-Jovin, T and Aguilar-Saavedra, J A and Agustoni, M and Ahlen, S P and Ahmadov, F and Aielli, G and Akerstedt, H and Åkesson, T P. A and Akimoto, G and Akimov, A V and Alberghi, G L and Albert, J and Albrand, S and Alconada Verzini, M J and Aleksa, M and Aleksandrov, I N and Alexa, C and Alexander, G and Alexandre, G and Alexopoulos, T and Alhroob, M and Alimonti, G and Alio, L and Alison, J and Allbrooke, B M. M and Allison, L J and Allport, P P and Almond, J and Aloisio, A and Alonso, A and Alonso, F and Alpigiani, C and Altheimer, A and Alvarez Gonzalez, B and Alviggi, M G and Amako, K and Amaral Coutinho, Y and Amelung, C and Amidei, D and Amor Dos Santos, S P and Amorim, A and Amoroso, S and Amram, N and Amundsen, G and Anastopoulos, C and Ancu, L S and Andari, N and Andeen, T and Anders, C F and Anders, G and Anderson, K J and Andreazza, A and Andrei, V and Anduaga, X S and Angelidakis, S and Angelozzi, I and Anger, P and Angerami, A and Anghinolfi, F and Anisenkov, A V and Anjos, N and Annovi, A and Antonaki, A and Antonelli, M and Antonov, A and Antos, J and Anulli, F and Aoki, M and Aperio Bella, L and Apolle, R and Arabidze, G and Aracena, I and Arai, Y and Araque, J P and Arce, A T. H and Arguin, J.-F and Argyropoulos, S and Arik, M and Armbruster, A J and Arnaez, O and Arnal, V and ... and ATLAS Collaboration and Brookhaven National Laboratory (BNL), Upton, NY (United States) and Partikel- och astropartikelfysik and Skolan för teknikvetenskap (SCI) and KTH and Fysik
The European Physical Journal C, ISSN 1434-6044, 11/2014, Volume 74, Issue 11, pp. 1 - 34
Journal Article